Global Membrane Oxygenator Market Overview:
A membrane oxygenator is a device that is used for the purpose of adding oxygen to, and further removing carbon dioxide from the blood. It can be mainly used in two primary modes, firstly to replicate the function of the lungs during the cardiopulmonary bypass (CPB), and secondly to oxygenate the blood for a longer term of life support, which is termed to be as extracorporeal membrane oxygenation, i.e. ECMO. A membrane oxygenator generally consists of a very thin gas permeable membrane that separates the blood and the gas flows inside the CPB circuit; furthermore, oxygen is diffused from the gas side into the blood, as well as carbon dioxide is diffused from the blood into the gas for the purpose of disposal. These membrane oxygenators can be further be classified into two types namely, the flat sheet and the hollow fiber membrane oxygenators. These segments of the membrane oxygenators are hereby expected to hold a highly dominant market share during the forecasted period owing to the fact that they cause comparatively less blood trauma, less hemolysis, and also less post-operative bleeding. Membrane oxygenators also have the advantage of decreasing the damage as well as thrombosis which is usually seen while using the bubble oxygenators. Hence, these all factors are thereby expected to boost the market near future.
- The Rise in Prevalence of Cardiovascular Diseases
- The Surge in Global Ageing Population
- An Increase in Awareness Regarding Health
- Greater Adoption of Surgical Intervention In Case of Cardiac Issues
- Increasing Use of Smart Medical Devices
- Complications Arising From Direct Contact with Blood, Blood Trauma, Infection
- High Cost of These Devices
- Rapid Technological Advancements
- Emerging Demand from EconomiesComplications Arising From Direct Contact with Blood, Blood Trauma, Infection
- High Cost of These Devices
- Lack of Awareness about Membrane Oxygenator
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Medtronic (Ireland), Terumo Cardiovascular Systems (United States), Medos AB (Sweden), Sorin Group (Italy), LivaNova Plc (United Kingdom), Microport (China), Nipro (Japan), Chalice Medical Limited (United Kingdom), Braile Biomedica (Brazil), Maquet (Germany) and Wego New Life Medical Devices (China). Analyst at AdvanceMarketAnalytics see European Players to retain maximum share of Global Membrane Oxygenator market by 2025. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Membrane Oxygenator market. Considering Market by End-User, the sub-segment i.e. Neonatal will boost the Membrane Oxygenator market. Considering Market by Material Type, the sub-segment i.e. Ceramics will boost the Membrane Oxygenator market. Considering Market by End-Use, the sub-segment i.e. Cardiac will boost the Membrane Oxygenator market.
On 14 Feb 2018, LivaNova Plc, which a leading medical technology company, had announced the acquisition of TandemLife, which was a privately held company that mainly focused on advanced cardiopulmonary temporary support solutions.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Membrane Oxygenator market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Membrane Oxygenator market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Membrane Oxygenator, Suppliers and Distributors of Membrane Oxygenator, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.